![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INFLAMMATION AND IMMUNOPHARMACOLOGY
Release by Reducing Calcium-Dependent Activation of Nuclear Factor-
B and Extracellular Signal-Regulated Kinase 1/2
Departments of Pharmacology (L.M., S.C.P., D.M.H., L.P.R., V.R.) and Surgery (L.P.R.), Southern Illinois University School of Medicine, Springfield, Illinois
Bacterial lipopolysaccharide (LPS) activates the immune system and promotes inflammation via Toll-like receptor (TLR) 4, which regulates the synthesis and release of tumor necrosis factor (TNF)-
and other inflammatory cytokines. Previous studies have shown that the nucleoside adenosine suppresses LPS-stimulated TNF-
release in human UB939 macrophages by activating an adenosine A3 receptor (A3AR) subtype on these cells. In this study, we examined the mechanism(s) underlying A3AR-dependent inhibition of TNF-
release in a mouse (RAW 264.7) cell line. Treatment of RAW 264.7 cells with LPS (3 µg/ml) increased TNF-
release, which was reduced in a dose-dependent manner by adenosine analogs N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA) and R-phenylisopropyladenosine and reversed by selective A3AR blockade. The increase in TNF-
release was preceded by an increase in intracellular Ca2+ levels. Inhibition of intracellular Ca2+ release by IB-MECA, a selective agonist of the A3AR, or with BAPTA-AM, an intracellular Ca2+ chelator, reduced LPS-stimulated TNF-
release. Activation of the A3AR or inhibition of intracellular Ca2+ release also reduced LPS-stimulated nuclear factor-
B (NF-
B) activation and extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation. Similar inhibition by A3AR was observed for LPS-stimulated inducible nitric-oxide synthase. These data support the contention that inhibition of LPS-stimulated release of inflammatory molecules, such as TNF-
and NO via the A3AR, involves suppression of intracellular Ca2+signaling, leading to suppression of NF-
B and ERK1/2 pathways.
Address correspondence to: Dr. Vickram Ramkumar, Dept. of Pharmacology, Southern Illinois University School of Medicine, P.O. Box 19230, Springfield, IL 62794-1222. E-mail: vramkumar{at}siumed.edu
This article has been cited by other articles:
![]() |
X. Liu, M. Yao, N. Li, C. Wang, Y. Zheng, and X. Cao CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages Blood, December 15, 2008; 112(13): 4961 - 4970. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Morschl, J. G. Molina, J. B. Volmer, A. Mohsenin, R. S. Pero, J.-S. Hong, F. Kheradmand, J. J. Lee, and M. R. Blackburn A3 Adenosine Receptor Signaling Influences Pulmonary Inflammation and Fibrosis Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 697 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, and G. Cairo Role of HIF-1 and NF-{kappa}B Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals J. Biol. Chem., July 25, 2008; 283(30): 20674 - 20686. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Kolachala, R. Bajaj, M. Chalasani, and S. V. Sitaraman Purinergic receptors in gastrointestinal inflammation Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G401 - G410. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Pingle, S. Jajoo, D. Mukherjea, L. F. Sniderhan, K. A. Jhaveri, A. Marcuzzi, L. P. Rybak, S. B. Maggirwar, and V. Ramkumar Activation of the Adenosine A1 Receptor Inhibits HIV-1 Tat-Induced Apoptosis by Reducing Nuclear Factor-{kappa}B Activation and Inducible Nitric-Oxide Synthase Mol. Pharmacol., October 1, 2007; 72(4): 856 - 867. [Abstract] [Full Text] [PDF] |
||||